A detailed history of Prairie View Partners, LLC transactions in Organon & Co. stock. As of the latest transaction made, Prairie View Partners, LLC holds 13 shares of OGN stock, worth $249. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 13 -0.0%
Holding current value
$249
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$23.4 - $34.25 $234 - $342
-10 Reduced 43.48%
13 $0
Q2 2022

Jul 22, 2022

BUY
$31.66 - $38.9 $316 - $389
10 Added 76.92%
23 $1,000
Q2 2021

Jul 23, 2021

BUY
$28.45 - $38.0 $369 - $494
13 New
13 $0

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.88B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Prairie View Partners, LLC Portfolio

Follow Prairie View Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prairie View Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prairie View Partners, LLC with notifications on news.